AKT1 and myasthenia gravis: Some studies have shown that AKT1 increased in patients with myasthenia gravis (Maurer et al. 2015; Fang et al. 2022), encoded serine-threonine protein kinase, which affected many biological processes including proliferation, metabolism, and angiogenesis (Sanchez-Gurmaches et al. 2019).